Jeffrey R. Jacobson MD
Critical Care Medicine
Professor and Senior Associate Head of Medicine, University of Illinois at Chicago
Join to View Full Profile
909 South Wolcott Avenue3141 COMRBChicago, IL 60612
Phone+1 312-996-8039
Fax+1 312-996-4665
Dr. Jacobson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2000 - 2004
NYU Grossman School of MedicineResidency, Internal Medicine, 1996 - 2000- New York University School of MedicineClass of 1996
Massachusetts Institute of TechnologyBS, Applied Mathematics, 1988 - 1992
Certifications & Licensure
IL State Medical License 2005 - 2026
FL State Medical License 2013 - 2018
MD State Medical License 2004 - 2006
NY State Medical License 1999 - 2001
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Increased Kindlin-2 via SMURF1 Inhibition Attenuates Endothelial Permeability and Acute Lung Injury.Weiguo Chen, Yulia Epshtein, Christen Vagts, Anne E Cress, Jeffrey R Jacobson
International Journal of Molecular Sciences. 2025-02-22 - Epigenetic mechanisms mediate cytochrome P450 1A1 expression and lung endothelial injury caused by MRSA in vitro and in vivo.Alison W Ha, Lucille N Meliton, Weiguo Chen, Lichun Wang, Mark Maienschein-Cline
FASEB Journal. 2024-11-30 - 2 citationsDeficiency of the Deubiquitinase UCHL1 Attenuates Pulmonary Arterial Hypertension.Haiyang Tang, Akash Gupta, Seth A Morrisroe, Changlei Bao, Tae-Hwi Schwantes-An
Circulation. 2024-07-23
Grant Support
- Fostering Academic Physician-Investigators Treating High Risk PopulationsUNIVERSITY OF ILLINOIS AT CHICAGO2021–2025
- Fostering Academic Physician-Investigators Treating High Risk PopulationsUNIVERSITY OF ILLINOIS AT CHICAGO2021–2025
- Sphingolipids as Novel Therapeutic Targets in Radiation Lung InjuryUNIVERSITY OF ILLINOIS AT CHICAGO2020–2025
- Integrin Beta 4 In Vascular Inflammatory ResponsesNational Heart, Lung, And Blood Institute2010–2011
- Integrin Beta 4 In Vascular Inflammatory ResponsesNational Heart, Lung, And Blood Institute2009
- Endothelial Barrier Regulation By SimvastatinNational Heart, Lung, And Blood Institute2005–2009
- Stretch-Induced Changes In Endothelial ContractilityNational Heart, Lung, And Blood Institute2002–2003
Professional Memberships
- Member
- Member
- Society of Critical Care MedicineMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
